Strain rate effect on the mechanical behaviour of a textile reinforced cement composite

The static tensile behaviour of Textile Reinforced Cement Composites is known and can be modeled adequately. However, using these static material properties under dynamic loadings such as impact and seismic loadings, can cause over- or underestimation of the material due to effects of strain rate. This work focuses on the strain rate dependency of a specific textile reinforced cement composite under tensile loadings at strain rates equivalent to quasi static applications towards low velocity impacts. It was found that the main damage mechanisms of this material stay the same. However cracking of the cement matrix is delayed to higher stress levels

Prediction of dynamic strains on a monopile offshore wind turbine using virtual sensors

The monitoring of the condition of the offshore wind turbine during its operational states offers the possibility of performing accurate assessments of the remaining life-time as well as supporting maintenance decisions during its entire life. The efficacy of structural monitoring in the case of the offshore wind turbine, though, is undermined by the practical limitations connected to the measurement system in terms of cost, weight and feasibility of sensor mounting (e.g. at muddline level 30m below the water level). This limitation is overcome by reconstructing the full-field response of the structure based on the limited number of measured accelerations and a calibrated Finite Element Model of the system. A modal decomposition and expansion approach is used for reconstructing the responses at all degrees of freedom of the finite element model. The paper will demonstrate the possibility to predict dynamic strains from acceleration measurements based on the aforementioned methodology. These virtual dynamic strains will then be evaluated and validated based on actual strain measurements obtained from a monitoring campaign on an offshore Vestas V90 3 MW wind turbine on a monopile foundation

Large-scale blast loading of a composite tube array for protection of civil engineering structures

C

Autonomous regeneration of concrete structures by incorporation of self-healing mechanisms

info:eu-repo/semantics/publishe

Overall survival, disease-specific survival and local recurrence outcomes in patients with muscle-invasive bladder cancer treated with external beam radiotherapy and brachytherapy: a systematic review

Introduction: Neoadjuvant chemotherapy followed by radical cystectomy (RC) and pelvic lymph node dissection is the standard radical management for muscle‐invasive bladder cancer (MIBC). However, major pelvic surgery is not suitable for all patients and combined modality therapy (CMT) offers an alternative for patients who want to retain their bladder. Brachytherapy (BT), as part of CMT, has been offered in selective cases of bladder cancer. Objectives: To evaluate the clinical effectiveness of BT for solitary urinary bladder tumours in terms of survival, local recurrence (LR) rates, and adverse events. Methods: A systematic review was conducted using defined search terms using online databases. Articles that discussed the use of BT as part of multi‐modality treatments for MIBC were included. Results: Searches returned 112 articles of which 20 were deemed suitable for analysis. In all, 15 of the 20 articles reported overall survival (OS) at 5 years, 2747 patients were at risk and 1670 were alive after 5 years (60%): seven studies reported OS at 10 years, with 817 patients at risk and 350 alive at 10 years (42%). Disease‐specific survival at 5 years was reported in four studies, with 371 patients at risk and 279 alive (75%) at 5 years. LR rates were reported across all 20 studies and ranged from 0% to 32%. Conclusion: Brachytherapy as part of CMT for MIBC is not a standard technique. It is an effective treatment in experienced centres for a selected patient population who wish to preserve their bladder. In such patients, CMT‐BT is well tolerated with an acceptable safety profile

COmparing Urolift and Standard Transurethral resection of prostate Ahead of Radiotherapy in men with urinary symptoms secondary to prostate enlargement in Southwest London and North Cumbria (CO-STAR): a study protocol for a randomised feasibility study

Introduction: Patients undergoing prostate radiotherapy with an enlarged prostate can have short-term and long-term urinary complications. Currently, transurethral resection of the prostate (TURP) is the mainstay surgical intervention for men with urinary symptoms due to an enlarged prostate prior to radiotherapy. UroLift (NeoTract, Pleasanton, CA, USA) is a recent minimally invasive alternative, widely used in benign disease but is untested in men with prostate cancer. // Methods and analysis: A multicentre, two-arm study designed in collaboration with a Patient Reference Group to assess the feasibility of randomising men with prostate cancer and coexisting urinary symptoms due to prostate enlargement to TURP or UroLift ahead of radiotherapy. 45 patients will be enrolled and randomised (1:1) using a computer-generated programme to TURP or UroLift. Recruitment and retention will be assessed over a 12 month period. Information on clinical outcomes, adverse events and costs will be collected. Clinical outcomes and patient reported outcome measures will be measured at baseline, 6 weeks postintervention and 3 months following radiotherapy. A further 12 in-depth interviews will be conducted with a subset of patients to assess acceptability using the Theoretical Framework of Acceptability. Descriptive analysis on all outcomes will be performed using Stata (StataCorp V.2021). // Ethics and dissemination: The trial has been approved by the Research Ethics Committee (REC) NHS Health Research Authority (HRA) and Health and Care Research Wales (HCRW). The results will be published in peer-reviewed journals, presented at national meetings and disseminated to patients via social media, charity and hospital websites. // Trial registration number: NCT05840549